Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy

Albershardt, Tina C; Parsons, Andrea J; ter Meulen, Jan; Berglund, Peter

doi:10.1186/2051-1426-3-S2-P346

Article metrics
Last updated: Fri, 19 Apr 2024 16:01:53 Z

Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy

Access & Citations

640

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.